Roger Adsett Insmed Inc (INSM) insider trading activity

Roger Adsett is Chief Operating Officer of INSMED Inc. Currently has a direct ownership of 105,637 shares of INSM, which is worth approximately $20 Million. The most recent transaction as insider was on Aug 19, 2025, when has been sold 25,000 shares (Common Stock) at a price of $127.85 per share, resulting in proceeds of $3,196,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K

19.14% 3M change

29.23% 12M change

Total Value Held $20 Million

Roger Adsett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 19 2025	SELL Open market or private sale	$3,196,250 $127.85 p/Share	25,000 Reduced 19.14%	105,637 Common Stock
Jun 16 2025	SELL Open market or private sale	$1,056,952 $98.91 p/Share	10,686 Reduced 7.56%	130,637 Common Stock
Jun 03 2025	SELL Open market or private sale	$132,990 $71.5 p/Share	1,860 Reduced 1.3%	141,323 Common Stock
May 15 2025	BUY Grant, award, or other acquisition	-	6,508 Added 4.35%	143,183 Common Stock
May 14 2025	SELL Open market or private sale	$126,299 $65.61 p/Share	1,925 Reduced 1.39%	136,675 Common Stock
May 13 2025	SELL Open market or private sale	$507,354 $67.81 p/Share	7,482 Reduced 5.12%	138,600 Common Stock
Feb 10 2025	SELL Open market or private sale	$3,362,364 $78.24 p/Share	42,975 Reduced 22.73%	146,082 Common Stock
Feb 07 2025	SELL Open market or private sale	$7,956 $79.57 p/Share	100 Reduced 0.05%	189,057 Common Stock
Feb 06 2025	SELL Open market or private sale	$3,689,444 $80.9 p/Share	45,605 Reduced 19.43%	189,157 Common Stock
Feb 05 2025	BUY Grant, award, or other acquisition	-	88,680 Added 27.42%	234,762 Common Stock
Jan 14 2025	SELL Open market or private sale	$100,125 $68.72 p/Share	1,457 Reduced 0.99%	146,082 Common Stock
Jan 10 2025	SELL Open market or private sale	$312,453 $63.74 p/Share	4,902 Reduced 3.22%	147,539 Common Stock
Jan 08 2025	SELL Open market or private sale	$124,400 $66.1 p/Share	1,882 Reduced 1.27%	145,784 Common Stock
Jan 08 2025	BUY Grant, award, or other acquisition	-	6,657 Added 4.18%	152,441 Common Stock
Jan 07 2025	SELL Open market or private sale	$161,181 $65.95 p/Share	2,444 Reduced 1.63%	147,666 Common Stock
May 17 2024	SELL Open market or private sale	$149,160 $25.09 p/Share	5,945 Reduced 3.83%	149,275 Common Stock
May 14 2024	SELL Open market or private sale	$200,353 $25.5 p/Share	7,857 Reduced 4.82%	155,220 Common Stock
May 13 2024	BUY Grant, award, or other acquisition	-	14,518 Added 8.17%	163,077 Common Stock
Jan 12 2024	SELL Open market or private sale	$150,336 $28.63 p/Share	5,251 Reduced 3.41%	148,559 Common Stock
Jan 10 2024	SELL Open market or private sale	$102,190 $28.9 p/Share	3,536 Reduced 2.25%	153,810 Common Stock
Jan 09 2024	SELL Open market or private sale	$112,232 $29.25 p/Share	3,837 Reduced 2.38%	157,346 Common Stock
Jan 05 2024	SELL Open market or private sale	$88,856 $29.21 p/Share	3,042 Reduced 1.85%	161,183 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	12,873 Added 7.27%	164,225 Common Stock
Jun 13 2023	SELL Open market or private sale	$173,512 $19.32 p/Share	8,981 Reduced 5.6%	151,352 Common Stock
May 17 2023	SELL Open market or private sale	$44,357 $18.12 p/Share	2,448 Reduced 1.5%	160,333 Common Stock

Also insider at

LABP

Landos Biopharma, Inc. Healthcare

Roger Adsett

Chief Operating Officer

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Value

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to INSMED Inc

Track Activities on INSM

Account